• COVAX Announces new agreement, plans for first deliveries

    COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements.Additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021, via existing agreements with the Serum Institute of India (SII) and AstraZeneca.COVAX is therefore on track to deliver at least 2 billion doses by the end of the year, including at least 1.3 billion doses to 92 lower income economies in the Gavi COVAX AMC.Click here for the latest COVAX supply forecast Geneva/Oslo 22 January 2021 – COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, today announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has […]

  • Statement on the sixth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

    The sixth meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (2005) (IHR) regarding the coronavirus disease (COVID-19) took place on Thursday, 14 January 2021 from 12:15 to 16:45 Geneva time (CEST). Proceedings of the meetingMembers and Advisors of the Emergency Committee were convened by videoconference. The Director-General welcomed the Committee, expressed the need for global solidarity in addressing the challenges posed by the pandemic, and emphasized the need for protection of the most vulnerable. He thanked the Committee for their continued support and advice. Representatives of the legal department and the Department of Compliance, Risk Management, and Ethics (CRE) briefed the members on their roles and responsibilities. The Ethics Officer from CRE provided the Members and Advisers with an overview of the WHO Declaration of Interest process. The Members and […]

  • Emergency Committee on COVID-19 advises on variants, vaccines

    The COVID-19 pandemic continues to constitute a Public Health Emergency of International Concern (PHEIC), according to the WHO Emergency Committee (EC) on COVID-19.The EC met virtually yesterday (14 January) at the request of WHO Director-General Dr Tedros Adhanom Ghebreyesus to review the emerging variants of SARS-CoV-2, the virus that causes COVID-19, and to consider the potential use of vaccination and testing certificates for international travel.On variants, the EC called for a global expansion of genomic sequencing and sharing of data, along with greater scientific collaboration to address critical unknowns.The committee urged WHO to develop a standardized system for naming new variants that avoids geographical markers, an area WHO has already begun work on.On vaccines, the committee underlined the need for equitable access through the COVAX Facility as well as technology transfer to increase global production capacities.The committee strongly encouraged vaccine manufacturers to […]

  • Strengthening vital partnership between WHO and France

    On 7 December 2020 high level representatives from the French government and WHO gathered virtually for their annual strategic dialogue to take stock of collaboration during the year 2020 and to discuss key joint priorities for collaboration for 2021. The objective of the meeting was to agree on specific ways to enhance cooperation and a road map around key areas: the WHO Academy, health emergencies preparedness and response, including COVID-19 response, investing in resilient health systems in particular through primary health care and multilateralism in health with a strengthened WHO as the leader in global health. “Today France and WHO are joining forces on top health priorities that deepens even more their already existing partnership,” said Ms Jane Ellison, WHO Executive Director for External Relations and Governance. “We are honoured to count France among our top contributors and strong supporters in all circumstances.”The meeting had a strong focus […]

  • UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile

    The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response.  The effort to establish the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which includes the World Health Organization (WHO), UNICEF, the International Federation of Red Cross and Red Crescent Societies (IFRC), and Médecins Sans Frontières (MSF), with financial support from Gavi, the Vaccine Alliance. The stockpile will allow countries, with the support of humanitarian organizations, to contain future Ebola epidemics by ensuring timely access to vaccines for populations at risk during outbreaks.The injectable single-dose Ebola vaccine (rVSV∆G-ZEBOV-GP, live) is manufactured by Merck, Sharp & Dohme (MSD) Corp. and developed with financial support from the from the government of the United States of America (USA). The European Medicines Agency licensed […]

  • COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

    COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donorsThese agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first half of 2021. At least 1.3 billion donor-funded doses will be made available to 92 economies eligible for the Gavi COVAX AMC, targeting up to 20% population coverage by the end of the year.Funding raised in 2020 and early pledges toward 2021 targets, alongside these agreements, offer clearest pathway yet to ending the acute phase of the pandemic globally by the end of 2021 Geneva/Oslo, 18 December 2020 – COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, today announced that it had arrangements in place to access nearly two billion doses […]

Are You Prepared?

Close Menu